トップへ戻る

※Package design is subject to change without notice.

  • Code:005339-002
  • Tsumura Juuzentaihoto[48] : 42 sachets(for two weeks)
  • $45.49

Up to 4 pieces per person

10% discount for total amount over $100

shipping schedule : about 3 weeks after payment

warehouse:Japan1

Manufacturer :TSUMURA & CO.

Brand :TSUMURA & CO.

JAN Code:----

  • Description
      Juzentaihoto is indicated for the relief of declined constitution after recovery from disease, fatigue and malaise, anorexia,perspiration during sleep, cold limbs, anemia.
  • Active Ingredients
      7.5 g (3sachets for 1day)of TSUMURA Juzentaihoto extract granules contains 5.0 g of a dried extract of the following mixed crude drugs.JP Astragalus Root 3.0 gJP Cinnamon Bark 3.0 gJP Rehmannia Root 3.0 gJP Peony Root 3.0 gJP Cnidium Rhizome 3.0 gJP Atractylodes Lancea Rhizome 3.0 gJP Japanese Angelica Root 3.0 gJP Ginseng 3.0 gJP Poria Sclerotium 3.0 gJP Glycyrrhiza 1.5 g(JP: The Japanese Pharmacopoeia)
  • Effect/Efficacy
      TJ-48 is indicated for the relief of declined constitution after recovery from disease, fatigue and malaise, anorexia, perspiration during sleep, cold limbs, anemia
  • Usage/Dosage
      The usual adult dose is 7.5 g/day orally in 2 or 3 divided doses before or between meals. The dosage may be adjusted according to the patient's age and body weight, and symptoms.
      (2)Patients with anorexia, nausea or vomiting [These symptoms may be aggravated.]

  • Cautions
      1.Careful administration(TJ-48should be administered with care in the following patients.)
      (1)Patients with an extremely weak gastrointestinal tract [Anorexia,
      epigastric distress, nausea, vomiting, diarrhea, etc. may occur.]

      2. Important Precautions
      (1)When TJ-48is used, the patient’s “SHO”(constitution/symptoms) should be taken into account. The patient’s progress should be carefully monitored, and if no improvement insymptoms/findings is observed, continuous treatment should be avoided.
      (2)Since TJ-48contains Glycyrrhiza, careful attention should be paid to the serum potassium level, blood pressure, etc., and if any abnormality is observed, administration should be discontinued.
      (3)When TJ-48is co-administered with other Kampo-preparations (Japanese traditional herbal medicines), etc., attention should be paid to the duplication of the contained crude drugs.

      SHO:
      The term“SHO” refers to a particular pathological status of a patient evaluated by the Kampo diagnosis, and is patterned according to the patient’s constitution, symptoms, etc.
      Kampo-preparations (Japanese traditional herbal medicines) should be used after confirmation that it is suitable for the identified “SHO” of the patient
  • Contraindication
      TJ-48has not been investigated (drug use investigations, etc.)to determine the incidence of adverse reactions. Therefore, the incidence of adverse reactions is not known.
      (1)Clinically significant adverse reactions
      1)Pseudoaldosteronism: Pseudoaldosteronism suchas hypokalemia, increased blood pressure, retention of sodium/body fluid, edema, increased body weight, etc. may occur. The patient should be carefully monitored (measurement of serum potassium level, etc.), and if any abnormality is observed, administration should be discontinued and appropriate measures such as administration of potassium preparations
      should be taken.
      2)Myopathy: Myopathy may occur as a result of hypokalemia. The patient should be carefully monitored, and if any abnormality such as weakness, convulsion/paralysis of limbs,etc. are observed, administration should be discontinued and appropriate measures such as administration of potassium preparations should be taken.
      3)Hepatic dysfunction and jaundice: Hepatic dysfunction and/or jaundice with elevation of AST(GOT), ALT(GPT), Al-P and GTP or other symptoms may occur
      The patient should be carefully monitored for abnormal findings.Administration should be discontinued and appropriate therapeutic measures should be taken, if abnormalities are observed.
Now Loading...

Now Loading...